Summit Therapeutics plc Share Price London S.E.
Stocks
GB00BN40HZ01
Biotechnology & Medical Research
| Market Cap | 796.74Cr 1.07TCr 936.72Cr 864.38Cr 1.5TCr 1,03200Cr 1.54TCr 10TCr 4.06TCr 51TCr 4.03TCr 3.94TCr 1,74000Cr | P/E 2026 * |
-12.1x | P/E 2027 * | -12.2x |
|---|---|---|---|---|---|
| Enterprise Value | 770.57Cr 1.04TCr 905.95Cr 835.98Cr 1.45TCr 1LCr 1.48TCr 9.99TCr 3.93TCr 49TCr 3.89TCr 3.81TCr 1,68300Cr | EV / Sales 2026 * |
3,148x | EV / Sales 2027 * | 189x |
| Free-Float |
16.86% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Summit Therapeutics plc
| Manager | Title | Age | Since |
|---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 54 | 25/07/2022 |
Robert Duggan
CEO | Chief Executive Officer | 81 | 01/04/2020 |
| Director of Finance/CFO | 48 | 02/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Duggan
CHM | Chairman | 81 | 01/02/2020 |
| Director/Board Member | 48 | 01/12/2019 | |
Mahkam Zanganeh
BRD | Director/Board Member | 54 | 11/11/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -2.38% | - | - | 1.07TCr | |
| +0.24% | -1.54% | +52.85% | +71.85% | 5.38TCr | |
| -7.17% | -4.39% | +42.72% | +73.32% | 5.21TCr | |
| +0.80% | -6.31% | +5.62% | +417.78% | 2.35TCr | |
| -0.09% | -0.01% | -16.85% | -15.41% | 2.31TCr | |
| -5.95% | -2.58% | +29.53% | -9.47% | 1.94TCr | |
| -1.14% | +0.03% | +31.67% | -30.65% | 1.76TCr | |
| -5.16% | -7.00% | +168.44% | +314.96% | 1.52TCr | |
| -6.91% | -5.83% | +25.17% | +644.30% | 1.48TCr | |
| +0.43% | -1.03% | +25.75% | +189.74% | 1.41TCr | |
| Average | -2.50% | -2.62% | +40.54% | +184.05% | 2.6TCr | |
| Weighted average by Cap. | -2.68% | -2.36% | +39.55% | +143.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 24.48L 32.93L 28.78L 26.55L 46.13L 32Cr 47.16L 3.17Cr 1.25Cr 16Cr 1.24Cr 1.21Cr 53Cr | 4.2Cr 5.65Cr 4.94Cr 4.56Cr 7.92Cr 544.56Cr 8.1Cr 55Cr 21Cr 266.7Cr 21Cr 21Cr 918.12Cr |
| Net income | -66Cr -88Cr -77Cr -71Cr -123.89Cr -8.52TCr -126.64Cr -852.32Cr -335.24Cr -4.17TCr -332.09Cr -324.8Cr -14TCr | -68Cr -92Cr -80Cr -74Cr -128.23Cr -8.81TCr -131.07Cr -882.18Cr -346.98Cr -4.32TCr -343.72Cr -336.18Cr -15TCr |
| Net Debt | -26Cr -35Cr -31Cr -28Cr -49Cr -3.39TCr -50Cr -339.35Cr -133.48Cr -1.66TCr -132.22Cr -129.32Cr -5.72TCr | -1.1Cr -1.49Cr -1.3Cr -1.2Cr -2.08Cr -143.15Cr -2.13Cr -14Cr -5.64Cr -70Cr -5.58Cr -5.46Cr -241.35Cr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
